Pathogenesis of non-alcoholic fatty liver disease

por Dowman, J. K., Tomlinson, J.W., Newsome, P.N.
Publicado 2010

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

por Dowman, J K, Tomlinson, J W, Newsome, P N
Publicado 2011

Short- and long-term glucocorticoid treatment enhances insulin signalling in human subcutaneous adipose tissue

por Gathercole, L L, Morgan, S A, Bujalska, I J, Stewart, P M, Tomlinson, J W
Publicado 2011

Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations

por De Alcubierre, D., Ferrari, D., Mauro, G., Isidori, A. M., Tomlinson, J. W., Pofi, R.
Publicado 2023

Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence

por Thangaratinam, S, Rogozińska, E, Jolly, K, Glinkowski, S, Roseboom, T, Tomlinson, J W, Kunz, R, Mol, B W, Coomarasamy, A, Khan, K S
Publicado 2012

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis

por Armstrong, M J, Hazlehurst, J M, Hull, D, Guo, K, Borrows, S, Yu, J, Gough, S C, Newsome, P N, Tomlinson, J W
Publicado 2014

A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis

por Bujalska, I J, Gathercole, L L, Tomlinson, J W, Darimont, C, Ermolieff, J, Fanjul, A N, Rejto, P A, Stewart, P M
Publicado 2008